Stephanie Robu

1.1k total citations
14 papers, 777 citations indexed

About

Stephanie Robu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Stephanie Robu has authored 14 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Stephanie Robu's work include Radiopharmaceutical Chemistry and Applications (7 papers), Peptidase Inhibition and Analysis (7 papers) and Prostate Cancer Treatment and Research (7 papers). Stephanie Robu is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (7 papers), Peptidase Inhibition and Analysis (7 papers) and Prostate Cancer Treatment and Research (7 papers). Stephanie Robu collaborates with scholars based in Germany, United States and Netherlands. Stephanie Robu's co-authors include Markus Schwaiger, Hans‐Jürgen Wester, Margret Schottelius, Tobias Maurer, Jürgen E. Gschwend, Matthias Eiber, Wolfgang Weber, Antonia Richter, Stephan G. Nekolla and Thomas Horn and has published in prestigious journals such as European Urology, Journal of Nuclear Medicine and Applied Radiation and Isotopes.

In The Last Decade

Stephanie Robu

14 papers receiving 774 citations

Peers

Stephanie Robu

PRM

RNMI

ONCOL

SURGE

Vincenzo Allegri Italy

Aurora Poon Australia

Matthias Saar Germany

Christoph Henkenberens Germany

Shinji Shinohara Japan

E. Edmund Kim United States

HJ Hoekstra Netherlands

Arif Sheikh United States

W. Torre Spain

Kgomotso Mokoala South Africa

Vincenzo Allegri Italy

Stephanie Robu

334 ×0.8

PRM

417 ×1.1

RNMI

392 ×1.3

ONCOL

177 ×1.0

SURGE

127 ×1.3

Citations per year, relative to Stephanie Robu Stephanie Robu (= 1×) peers Vincenzo Allegri

Countries citing papers authored by Stephanie Robu

Since Specialization

Citations

This map shows the geographic impact of Stephanie Robu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Robu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Robu more than expected).

Fields of papers citing papers by Stephanie Robu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Robu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Robu. The network helps show where Stephanie Robu may publish in the future.

Co-authorship network of co-authors of Stephanie Robu

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Robu. A scholar is included among the top collaborators of Stephanie Robu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Robu. Stephanie Robu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Morath, Volker, Markus R. Anneser, Tarik Bozoglu, et al.. (2025). PET-based tracking of CAR T cells and viral gene transfer using a cell surface reporter that binds to lanthanide complexes. PubMed. 9(11). 1886–1906. 2 indexed citations

Robu, Stephanie, Antonia Richter, Christof Seidl, et al.. (2021). Synthesis and Preclinical Evaluation of a ⁶⁸Ga-Labeled Adnectin, ⁶⁸Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression. Journal of Nuclear Medicine. 62(9). 1228–1234. 27 indexed citations

Nekolla, Stephan G., Stephanie Robu, Christian Kupatt, et al.. (2021). Imaging of cardiac fibroblast activation in a patient after acute myocardial infarction using 68Ga-FAPI-04. Journal of Nuclear Cardiology. 29(5). 2254–2261. 48 indexed citations

Wurzer, Alexander, Michael Herz, Antonia Richter, et al.. (2021). Automated synthesis of [18F]Ga-rhPSMA-7/ -7.3: results, quality control and experience from more than 200 routine productions. EJNMMI Radiopharmacy and Chemistry. 6(1). 14 indexed citations

Richter, Antonia, Karina Knorr, Martin Schlapschy, et al.. (2020). First In-Human Medical Imaging with a PASylated 89Zr-Labeled Anti-HER2 Fab-Fragment in a Patient with Metastatic Breast Cancer. Nuclear Medicine and Molecular Imaging. 54(2). 114–119. 30 indexed citations

Horn, Thomas, Martin Krönke, Isabel Rauscher, et al.. (2019). Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer. European Urology. 76(4). 517–523. 67 indexed citations

Varasteh, Zohreh, Sarajo K. Mohanta, Stephanie Robu, et al.. (2019). Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a ⁶⁸Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04. Journal of Nuclear Medicine. 60(12). 1743–1749. 179 indexed citations

Singh, Baljinder, Ashwani Koul, Anil K. Mishra, et al.. (2019). Radiosynthesis and pre-clinical evaluation of [ Ga] labeled antimicrobial peptide fragment GF-17 as a potential infection imaging PET radiotracer. Applied Radiation and Isotopes. 149. 9–21. 8 indexed citations

Varasteh, Zohreh, Miriam Braeuer, Stephanie Robu, et al.. (2019). PET molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labelled fibroblast activation protein inhibitor (FAPI-04). Nuklearmedizin - NuclearMedicine. 2 indexed citations

10.

Wirtz, Martina, Alexander Schmidt, Margret Schottelius, et al.. (2018). Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity. EJNMMI Research. 8(1). 84–84. 28 indexed citations

11.

Maurer, Tobias, Stephanie Robu, Margret Schottelius, et al.. (2018). 99mTechnetium-based Prostate-specific Membrane Antigen–radioguided Surgery in Recurrent Prostate Cancer. European Urology. 75(4). 659–666. 168 indexed citations

12.

Robu, Stephanie, Alexander Schmidt, Matthias Eiber, et al.. (2018). Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007. EJNMMI Research. 8(1). 30–30. 38 indexed citations

13.

Robu, Stephanie, Margret Schottelius, Matthias Eiber, et al.. (2016). Preclinical Evaluation and First Patient Application of^99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer. Journal of Nuclear Medicine. 58(2). 235–242. 165 indexed citations

14.

Weineisen, Martina, et al.. (2015). Neue und bewährte Radiopharmaka für die Diagnostik und Therapie des Prostatakarzinoms. Der Nuklearmediziner. 38(2). 89–98. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact